Article

Durable tracking anti-SARS-CoV-2 antibodies of cancer patients recovered from COVID-19

2021-04-28

Abstract excerpt

Cancer patients are more susceptible to SARS-CoV-2 infection and generally have higher mortality rate. Anti-SARS-CoV-2 IgG is an important consideration for the patients in this COVID-19 pandemic. Recent researches suggested the rapid decay of anti-SARS-CoV-2 antibodies in the general population, but the decline rate of the antibodies in cancer patients was unknown. In this observational study, we reported the cli...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 5c754eb0-4e5c-54e6-a806-99ab41b40158
DOI: 10.21203/rs.3.rs-428122/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Durable tracking anti-SARS-CoV-2 antibodies of cancer patients recovered from COVID-19DOI 10.21203/rs.3.rs-428122/v1Read

Functional antibody and T-cell immunity following SARS-CoV-2 infection, including by variants of concern, in patients with cancer: the CAPTURE studySemantic proximity Read

Antibody Responses to SARS-CoV-2 Infection in Cancer PatientsSemantic proximity Read

Anti-SARS-CoV-2 antibody containing plasma improves outcome in patients with hematologic or solid cancer and severe COVID-19 via increased neutralizing antibody activity – a randomized clinical trialSemantic proximity Read

Immunogenicity of SARS-CoV-2 mRNA Vaccines in Patients with Cancer: Findings from an International Collaborative Cohort StudySemantic proximity Read

Adaptive immunity and neutralizing antibodies against SARS-CoV-2 variants of concern following vaccination in patients with cancer: The CAPTURE studySemantic proximity Read

Immunogenicity of SARS-CoV-2 mRNA Vaccines in Patients with Cancer: Findings from an International Collaborative Cohort StudySemantic proximity Read

Scottish COVID CAncer iMmunity Prevalence (SCCAMP) - a longitudinal study of patients with cancer receiving active anti-cancer treatment during the COVID-19 pandemicSemantic proximity Read

Scottish COVID Cancer Immunity Prevalence (SCCAMP) - a Longitudinal Study of Patients with Cancer Receiving Active Anti-Cancer Treatment During the COVID-19 PandemicSemantic proximity Read

Prevalence of IgG Antibodies to SARS-CoV-2 in Wuhan – Implications for the Longevity of Antibodies Against SARS-CoV-2Semantic proximity Read

Breakthrough SARS-CoV-2 Infections Among Patients with Cancer Following Two and Three Doses of COVID-19 mRNA VaccinesSemantic proximity Read

Impaired neutralizing antibody response to COVID-19 mRNA vaccines in cancer patientsSemantic proximity Read

The Dynamic Changes of Antibodies against SARS-CoV-2 during the Infection and Recovery of COVID-19Semantic proximity Read